Literature DB >> 1986852

Research in cancer pain. What we know and what we need to know.

C Cleeland1.   

Abstract

Entities:  

Mesh：

Year:  1991        PMID： 1986852     DOI： 10.1002/1097-0142(19910201)67:3+<823::aid-cncr2820671412>3.0.co;2-s

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  26 in total

1.  Efficacy of an intervention for fatigue and sleep disturbance during cancer chemotherapy.

Authors:  Andrea Barsevick; Susan L Beck; William N Dudley; Bob Wong; Ann M Berger; Kyra Whitmer; Tracey Newhall; Susan Brown; Katie Stewart
Journal:  J Pain Symptom Manage       Date:  2010-06-18       Impact factor: 3.612

2.  Trajectories of pain and analgesics in oncology outpatients with metastatic bone pain during participation in a psychoeducational intervention study to improve pain management.

Authors:  Dale J Langford; Steven M Paul; Debu Tripathy; Claudia West; Marylin J Dodd; Karen Schumacher; Christine Miaskowski
Journal:  J Pain       Date:  2011-03-22       Impact factor: 5.820

3.  The Brief Pain Inventory and its "pain at its worst in the last 24 hours" item: clinical trial endpoint considerations.

Authors:  Thomas M Atkinson; Tito R Mendoza; Laura Sit; Steven Passik; Howard I Scher; Charles Cleeland; Ethan Basch
Journal:  Pain Med       Date:  2010-01-15       Impact factor: 3.750

4.  Roux Limb Motility in Gastric Bypass Patients with Chronic Abdominal Pain-Is There an Association to Prescribed Opioids?

Authors:  Per Björklund; Almantas Maleckas; Hans Lönroth; Niclas Björnfot; Sven Egron Thörn; Lars Fändriks
Journal:  Obes Surg       Date:  2019-12       Impact factor: 4.129

5.  Trajectories of pain and analgesics in oncology outpatients with metastatic bone pain.

Authors:  Dale J Langford; Debu Tripathy; Steven M Paul; Claudia West; Marylin J Dodd; Karen Schumacher; Christine Miaskowski
Journal:  J Pain       Date:  2011-02-18       Impact factor: 5.820

6.  Reduction in opioid-related adverse events and improvement in function with parecoxib followed by valdecoxib treatment after non-cardiac surgery: a randomized, double-blind, placebo-controlled, parallel-group trial.

Authors:  Richard M Langford; Girish P Joshi; Tong J Gan; Maria Stoeckl Mattera; Wen-Hung Chen; Dennis A Revicki; Connie Chen; Gergana Zlateva
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

7.  Neuropathic and nociceptive pain in head and neck cancer patients receiving radiation therapy.

Authors:  Joel B Epstein; Diana J Wilkie; Dena J Fischer; Young-Ok Kim; Dana Villines
Journal:  Head Neck Oncol       Date:  2009-07-14

8.  Predictors of high score patient-reported barriers to controlling cancer pain: a preliminary report.

Authors:  Jung Hye Kwon; Sung Yong Oh; Gary Chisholm; Jung-Ae Lee; Jae Jin Lee; Keon Woo Park; Seung-Hyun Nam; Hun Ho Song; Keehyun Lee; Dae Young Zang; Ho Young Kim; Dae Ro Choi; Hyo Jung Kim; Jung Han Kim; Joo Young Jung; Geundoo Jang; Hyeong Su Kim; Ji Yun Won; Eduardo Bruera
Journal:  Support Care Cancer       Date:  2012-11-15       Impact factor: 3.603

9.  Oral alpha-lipoic acid to prevent chemotherapy-induced peripheral neuropathy: a randomized, double-blind, placebo-controlled trial.

Authors:  Ying Guo; Desiree Jones; J Lynn Palmer; Arthur Forman; Shaker R Dakhil; Maria R Velasco; Matthias Weiss; Paul Gilman; G M Mills; Stephen J Noga; Cathy Eng; Michael J Overman; Michael J Fisch
Journal:  Support Care Cancer       Date:  2013-12-22       Impact factor: 3.603

10.  [Slow-release morphine liquid suspension for the therapy of cancer pain and non-cancer pain-A pilot study.].

Authors:  M Strumpf; B Donner; M Zenz
Journal:  Schmerz       Date:  1995-05       Impact factor: 1.107
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.